Our Mission
At SciBase, we develop, manufacture and commercialize Nevisense, a groundbreaking point-of-care platform that integrates AI (augumented intelligence) and advanced EIS technology to improve diagnostic accuracy. Our mission is to ensure proactive skin health management and early detection of skin cancer and skin disorders.
Our unique platform
Nevisense
Nevisense combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer. The non-invasive Nevisense procedure provides clinicians with objective, actionable data at the point of care. Developed through more than 20 years of research at the Karolinska Institute and extensive clinical experience, Nevisense represents a breakthrough in dermatological diagnostics.
Events
We follow
Our commitment
At SciBase, we are committed to minimizing patient suffering and empowering clinicians to save lives through the early detection and intervention of skin diseases. By providing timely diagnostic support, we help reduce healthcare costs while improving patient outcomes.
Skin Barrier Assessment
For Research and Cosmetic Testing
Nevisense is a unique, AI-based platform for the non-invasive, assessment of the skin barrier function. The measurements provide researchers and developers with objective and actionable data at point-of-care. Nevisense provides the the ability to monitor therapeutic improvements and disease progression, while detecting non-visual and subclinical inflammation.